ACAM-CDIFF: Phase IIb started

sanofi's sanofi pasteur S.A. vaccines unit began a double-blind, placebo-controlled, U.K. Phase llb trial (H-030-011) to evaluate intramuscular ACAM-CDIFF in about 700 patients with acute C. difficile...